M-ATORVASTATIN

mantra pharma inc🇨🇦 Health Canada

Approval Id: bd372c2e3e45adb3
Drug Approval Canada Name: M-ATORVASTATIN
Product Name: M-ATORVASTATIN
Status: Marketed
Status Date: 2024-03-20
Original Market Date: 2018-03-07
Din: 02471191
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA05 ATORVASTATIN
Atc Name: c 10 aa 05
Aig Number: 0133055004
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

ATORVASTATIN (ATORVASTATIN CALCIUM)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bd372c2e3e45adb3

Type

Standard